… cell-based therapies as a tool to combat COVID-19, focusing especially … therapies focusing
on mediating NK cell activity to mitigate the immunopathological consequences of COVID-19, …

… In conclusion, the treatment strategy for patients with COVID-19 should be carefully designed
based on both viral kinetics and immunopathogenesis. However, pandemic infection with …

… Finally, we critically consider the various immuno-modifying drugs useful in the treatment of
Covid-19 and underline how the immunotherapeutic approach is of fundamental importance …

… action have been used for COVID-19 patients in clinical trials, … immunomodulatory drugs
administered to treat COVID-19 or … storm incidence and promising therapeutic agents that can …

… patients with COVID-19 must … immunopathology of COVID-19, its potential mechanisms,
and clinical implications to aid the development of new therapeutic strategies against COVID-19…

… immunopathogenesis of SARS-CoV-2 in humans and to provide insight into more effective
therapeutic … Here, we describe the immune responses and immunopathogenesis of COVID-19…

… strategy to improve the outcome for COVID-19. Therefore, we summarized current opinion
on the use of several drugs targeting immunopathology in COVID-19 by reviewing the practice …

… It is contemplated that the use of IL-6R as a therapeutic agent may be beneficial due to the
role of IL-6 in tissue repair. However, studies showed that the timing of administration of IL-6R …

… of immunopathogenesis of COVID-19 will help in designing suitable immune therapy for the
… In this review, we have discussed the pathogenesis and immunopathogenesis of COVID-19 …

… storm in critically ill patients with COVID-19. Corticosteroids such as dexamethasone and
methylprednisolone have been considered effective therapeutic agents to control the pro-…